*Youll have support from our clinic throughout the term of your program to answer questions about side effects, dosing, and more
Reduce Volume Before Reducing Intensity Your instinct might be to lighten the weights
[PMID: 33898844] PubMed record related to this compound for laboratory literature review
Glucagon-like peptide-1 agonists (GLP-1RA, GLP-1DAs, incretin mimetics, or GLP-1 analogs) represent a category of therapeutics used in the treatment of type 2 diabetes mellitus (T2DM) and obesity
People with diabetes, pancreatitis, gallbladder disease, or taking certain medications require particular caution and specialist monitoring with this combination
For most patients at 0.5 mg who have not achieved treatment goals, the appropriate next step is increasing to 1 mg weekly after at least four weeks at the current dose, provided the medication is well-tolerated